Mind Medicine Inc (NAS:MNMD)
$ 7.955 -0.305 (-3.69%) Market Cap: 586.65 Mil Enterprise Value: 324.11 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 41/100

Q2 2023 Mind Medicine (MindMed) Inc Earnings Call Transcript

Aug 03, 2023 / 08:30PM GMT
Release Date Price: $4.71 (+2.61%)
Operator

Good afternoon, and welcome to Mind Medicine second-quarter 2023 financial results and corporate update conference call. (Operator Instructions) This call is being webcast live on the Investors and Media section of MindMed's website at mindmed.co, and a recording will be available after the call.

For opening remarks, I would like to introduce Rob Barrow, CEO of MindMed. Please go ahead.

Rob Barrow;MindMed;Inc.;CEO;Board Director
Mind Medicine

()-&

Thank you, and good afternoon, everyone. Welcome to our second-quarter 2023 financial results and corporate update conference call.

The press release reporting our financial results is available in the Investors and Media section of our website. And our quarterly report on Form 10-Q for the quarter ended June 30, 2023, will be filed today with the Securities and Exchange Commission. Joining me today is Schond Greenway, our Chief Financial Officer; Dr. Dan Karlin, our Chief Medical Officer; and Dr. Miri Halperin Wernli, our Executive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot